Medicine & Life Sciences
Pharmacokinetics
100%
Healthy Volunteers
50%
Cross-Over Studies
16%
Tablets
16%
Therapeutic Equivalency
15%
Pharmaceutical Preparations
14%
Genotype
13%
Metformin
13%
Area Under Curve
13%
fimasartan
12%
Volunteers
11%
Placebos
11%
Safety
11%
Population
10%
Genetic Polymorphisms
10%
Cytochrome P-450 CYP3A
10%
Cytochrome P-450 CYP2C19
9%
Oral Administration
7%
LC15-0444
6%
Confidence Intervals
6%
Urine
6%
4-(3-amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(tert-butoxymethyl)piperazin-2-one
6%
Rosuvastatin Calcium
6%
Metabolomics
6%
udenafil
6%
Liquid Chromatography
6%
Drug Monitoring
6%
Cytochrome P-450 CYP2D6
6%
Therapeutics
6%
Korea
5%
Rifampin
5%
Epoxide Hydrolases
5%
Dipeptidyl-Peptidase IV Inhibitors
5%
Serum
5%
Amlodipine
5%
Vancomycin
5%
Busulfan
5%
Alleles
5%
Chemical Compounds
Pharmacokinetics
21%
Dose
8%
Fimasartan
7%
Peak Plasma Concentration
6%
Plasma
6%
Rosuvastatin
5%